J PHARM SCI-US 润色咨询

JOURNAL OF PHARMACEUTICAL SCIENCES

出版年份：1961 年文章数：7328 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：10.8% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=483014, encodeId=6f2048301469, content=连续3年2.9 ++++ 总算跨3了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 30 14:29:00 CST 2011, time=2011-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473349, encodeId=bd7b4e33497e, content=呃 放反反复复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=601, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=嗯嗯, createdTime=Fri Jan 14 13:55:00 CST 2011, time=2011-01-14, status=1, ipAttribution=)]
    2011-06-30 匿名用户

    连续3年2.9 ++++ 总算跨3了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=483014, encodeId=6f2048301469, content=连续3年2.9 ++++ 总算跨3了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=590, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 30 14:29:00 CST 2011, time=2011-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473349, encodeId=bd7b4e33497e, content=呃 放反反复复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=601, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=嗯嗯, createdTime=Fri Jan 14 13:55:00 CST 2011, time=2011-01-14, status=1, ipAttribution=)]
    2011-01-14 嗯嗯

    呃 放反反复复

    0

共17条页码: 2/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分